Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia
Abstract Critical limb ischemia (CLI), the terminal stage of peripheral arterial disease (PAD), is characterized by an extremely high risk of amputation and vascular issues, resulting in severe morbidity and mortality. In patients with severe limb ischemia with no alternative therapy options, such a...
Main Authors: | Zeinab Shirbaghaee, Mohammad Hassani, Saeed Heidari Keshel, Masoud Soleimani |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-022-03148-9 |
Similar Items
-
Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)
by: Zeinab Shirbaghaee, et al.
Published: (2023-07-01) -
Mesenchymal Stem/Stromal Cells for Therapeutic Angiogenesis
by: Farina Mohamad Yusoff, et al.
Published: (2023-08-01) -
Combined intra-arterial and intra-muscular transfer
of Wharton’s jelly mesenchymal stem/stromal cells in
no-option critical limb ischemia – the CIRCULATE N-O CLI Pilot Study
by: Tomasz Kwiatkowski, et al.
Published: (2022-11-01) -
Injectable thermosensitive selenium-containing hydrogel as mesenchymal stem cell carrier to improve treatment efficiency in limb ischemia
by: Xuan Tian, et al.
Published: (2024-04-01) -
The comparison of adipose-derived stromal cells (ADSCs) delivery method in a murine model of hindlimb ischemia
by: Ewelina Pilny, et al.
Published: (2024-02-01)